Tag Archives: Archives of General Psychiatry

Seven Ways Medical Conflicts of Interest are Disguised

The American Psychiatric Association, in its 240 page guide to its May annual meeting, “forgot” to mention the conflicts of interest of its own president Alan Schatzberg, MD. It had to print them on the newsletter circulated the third day of the meeting. Nor were names even alphabetized for easy information retrieval. (Schatzberg is financially linked to Eli Lilly, GSK, Merck, Pfizer, Forest, Takeda, Sanofi-Aventis and eight other companies.)

Note to all press running “ADHD linked to depression/suicide” study—its bogus

A cursory look at the study purporting that “ADHD in Children Linked to Depression and Higher Suicide Risk” revealed its obvious and glaring flaws and we are forced to ask why so-called medical websites such as WebMD or Medical News Today were unable to accomplish what took us about ½ hour to uncover—what was clearly omitted from this “study.”

Leading psychologist says antidepressants no better than placebo—the difference is no suicidal side effects with placebo

We spend more than £250 m a year on antidepressants in the UK – and it’s a complete waste of money. They are not much better than sugar pills, they have nasty side – effects, such as sexual dysfunction, and they increase young people’s risk of suicide. New research shows they don’t even work on the brain in the way we thought they did.

Natural News – “The U.S. is a nation seemingly hooked on mind-altering drugs”

Think Americans are maxed out on the number of psychiatric meds that huge numbers of them are taking? Think again. A new report says U.S. adults are increasingly being prescribed combinations of antidepressants, anti-anxiety and antipsychotic medications — and they could be experiencing serious side effects as a result.

Psychiatry’s Growing Practice of Multiple Prescriptions: 60% of patients drugged were given multiple prescriptions

About 60% of patients with psychiatrist office visits leading to a drug prescription received at least two medications in 2005-2006, according to government survey data. That was up from about 43% in 1996-1997. “These trends put patients at increased risk of drug-drug interactions with uncertain gains for quality of care and clinical outcomes,” the researchers stated.